Literature DB >> 26626960

Correlation between clinical symptoms and peripheral immune response in HAM/TSP.

George Alberto da Silva Dias1, Rita Catarina Medeiros Sousa1, Letícia Figueiredo Gomes2, Cezar Augusto Muniz Caldas2, Reza Nassiri3, Juarez Antônio Simões Quaresma1, Hellen Thais Fuzii4.   

Abstract

HTLV-1 infects principally CD4+ T cells that are the main reservoirs of the virus in vivo, which play an important role in the immunological response. Most of the infected patients are asymptomatic. However, 2-3% of patients will develop HAM/TSP or Adult T lymphoma. HAM/TSP is a chronic inflammatory disease of the central nervous system, which is characterized by unremitting myelopathic symptoms. Studies have shown that cytokines levels alterations (IFN-γ and TNF-α) were associated with tissue injury in HAM/TSP. The aims of this study were to compare the gene expression of IFN-γ, IL-4 and IL-10 of asymptomatic and HAM/TSP HTLV-1 infected patients, and to correlate the gene expression with those of clinical symptoms. 28 subjects were included, 20 asymptomatic HTLV-1 and 8 with HAM/TSP. Spasticity was evaluated using the Modified Ashworth Scale and the degree of walking aid was classified on a progressive scale. The relative gene expression of IFN-γ, IL-4, and IL-10 was measured by Real-Time PCR. Results showed high gene expression of IFN-γ for all patients, but it was higher among HAM/TSP. A significant correlation was observed between IFN-γ gene expression and the degree of walking aid, and IFN-γ gene expression was higher among wheelchair users compared to non-wheelchair users. No association was found with IL-4 and IL-10. These findings indicate that HAM/TSP patients express higher amounts of IFN-γ than asymptomatic patients, and more importantly, the expression of this cytokine was strongly correlated with the need of walking aid.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  HAM/TSP; HTLV-1; Immune response; Walking aids; spasticity

Mesh:

Substances:

Year:  2015        PMID: 26626960     DOI: 10.1016/j.micpath.2015.11.018

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  6 in total

Review 1.  Human T cell leukemia virus type 1 and Zika virus: tale of two reemerging viruses with neuropathological sequelae of public health concern.

Authors:  DeGaulle I Chigbu; Pooja Jain; Brenndan L Crumley; Dip Patel; Zafar K Khan
Journal:  J Neurovirol       Date:  2019-01-28       Impact factor: 3.739

2.  Cytokine profile and proviral load among Japanese immigrants and non-Japanese infected with HTLV-1 in a non-endemic area of Brazil.

Authors:  João Américo Domingos; Luana Silva Soares; Larissa M Bandeira; Camila Mareti Bonin; Ana C P Vicente; Louise Zanella; Marco Antonio Moreira Puga; Inês Aparecida Tozetti; Ana Rita Coimbra Motta-Castro; Rivaldo Venâncio da Cunha
Journal:  PLoS One       Date:  2017-04-04       Impact factor: 3.240

3.  HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina.

Authors:  Paula Benencio; Sindy A Fraile Gonzalez; Nicolás Ducasa; Kimberly Page; Carolina A Berini; Mirna M Biglione
Journal:  Retrovirology       Date:  2020-09-03       Impact factor: 4.602

Review 4.  Immunopathogenesis and Cellular Interactions in Human T-Cell Leukemia Virus Type 1 Associated Myelopathy/Tropical Spastic Paraparesis.

Authors:  Sepehr Aghajanian; Majid Teymoori-Rad; Ghazale Molaverdi; Sayed-Hamidreza Mozhgani
Journal:  Front Microbiol       Date:  2020-12-22       Impact factor: 5.640

5.  IFNG +874A/T Polymorphism Among Asymptomatic HTLV-1-Infected Individuals Is Potentially Related to a Worse Prognosis.

Authors:  Maria A F Queiroz; Vânia N Azevedo; Ednelza da S G Amoras; Tuane C F Moura; Marluísa de O Guimarães Ishak; Ricardo Ishak; Antonio C R Vallinoto; Rosimar N Martins Feitosa
Journal:  Front Microbiol       Date:  2018-05-18       Impact factor: 5.640

Review 6.  Influence of Immunogenetic Biomarkers in the Clinical Outcome of HTLV-1 Infected Persons.

Authors:  Antonio Carlos Rosário Vallinoto; Izaura Cayres-Vallinoto; Maria Alice Freitas Queiroz; Marluísa de Oliveira Guimarães Ishak; Ricardo Ishak
Journal:  Viruses       Date:  2019-10-23       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.